Expression of the uptake drug transporter hoct1 is animportant clinical determinant of the response to imatinib in chronic myeloid leukemia
Answers
Answered by
5
☆Some chronic myeloid leukemia(CML) patients do not respond to imatinib, whereas others lose an initialresponse.
Ritiksuglan:
hi genius
Similar questions